A drug with the SMILES Cc1ccc2nc(C)c(CN3CCN(c4ccc([N+](=O)[O-])cc4Cl)CC3)n2c1 has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM of -69.253%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1ccc2nc(C)c(CN3CCN(c4ccc([N+](=O)[O-])cc4Cl)CC3)n2c1
Cc1ccc2nc(C)c(CN3CCN(c4ccc([N+](=O)[O-])cc4Cl)CC3)n2c1
3-[[4-(2-chloro-4-nitrophenyl)piperazin-1-yl]methyl]-2,6-dimethylimidazo[1,2-a]pyridine